Journal of Functional Foods · 2020 · 28 citations · 46 references
Life SciencesNutritionNutritional SciencesMetabolic RegulationMetabolismMicrobial PhysiologyLactic Acid BacteriaLipid MetabolismMetabolic SignalingProbioticsWeight LossWeight ManagementCholesterol-lowering EffectsHigh-density Lipoprotein Cholesterol ModulationHigh-fat Diet-induced Liver InjuryLow-density Lipoprotein Cholesterol LoweringLow-density Lipoprotein Cholesterol ReductionMetabolic Response To DietPhosphatase InhibitionProbiotic Intervention
In this study, an in vivo lipid-lowering animal experiment was performed on Lactobacillus plantarum KFY02 (LP-KFY02) newly isolated from Xinjiang fermented yogurt. The study used a high-fat diet (HFD) to induce obese mice. Serum and tissue samples from mice were examined by molecular biological detection. The results indicated that LP-KFY02 could inhibit increases in various organ indexes of mice caused by HFD. LP-KFY02 could reduce the levels of alkaline phosphatase (AKP), alanine aminotransferase (ALT), aspartate aminotransferase (AST), triglyceride (TG), total cholesterol (TC), and low-density lipoprotein cholesterol (LDL-c) in the serum and liver of obese mice with HFD and improve high-density lipoprotein cholesterol (HDL-C) levels. Observation of pathological changes also showed that LP-KFY02 could alleviate the damage caused by obesity on the tissue samples from the liver of mice and reduce the expansion of fat cells. The results of qPCR experiments further showed that LP-KFY02 could effectively up-regulate the mRNA expression of lipoprotein lipase (LPL), peroxisome proliferative-activating receptor α (PPAR-α), cholesterol 7α-hydroxylase (CYP7A1), and carnitine palmitoyltransferase 1A (CPT1A) in the liver and epididymal adipose tissues, as well as cut down the mRNA expression of peroxisome proliferative-activating receptor γ (PPAR-γ) and CCAAT enhancer-binding proteins (C/EBP-α). Furthermore, ELISA results showed LP-KFY02 obviously decreased the level of pro-inflammatory factors interleukin (IL)-6, TNF-α, IL-1β and IFN-γ in serum, but increased the anti-inflammatory factors IL-4 and IL-10 content. LP-KFY02 could effectively treat obesity arose from HFD, and its effect is comparable to commercially available L-carnitine, and superior to the Lactobacillus delbruechii subsp. bulgaricus commonly used in industry. LP-KFY02 is a health beneficial strain with probiotic potential.
46
Zhidan Wu, Yuanyuan Xie, Ron F. Morrison et al. · Journal of Clinical Investigation · 1998 · 358 citations · Full text
Hui‐Young Lee, Jong‐Hwan Park, Jong‐Hwan Park et al. · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · 2006 · 341 citations
Wurong Ding, Chao Shi, Ming Chen et al. · Journal of Functional Foods · 2017 · 139 citations · Full text
Dezhen Wang, Sen Yan, Jin Yan et al. · Environmental Pollution · 2018 · 123 citations